RT @doctorRBC: Promising data on denosumab in erosive OA Phase 2 study - less erosive progression, more symptom improvem
Tweet Content
Promising data on denosumab in erosive OA
Phase 2 study - less erosive progression, more symptom improvement
Abs# L05 @RheumNow #ACR22 https://t.co/9Fg3r02ZQG
Show on Archive Page
On
Display in Search Results
On
PDQ
Off